Myriad Women's Health, Inc., headquartered in the United States, is a leading player in the women's health industry, specialising in genetic testing and personalised medicine. Founded in 2018, the company has quickly established itself as a pioneer in providing innovative solutions for women's health issues, particularly in areas such as hereditary cancer risk assessment and reproductive health. With a focus on empowering women through advanced genetic insights, Myriad offers unique products like the Myriad myRisk® test, which assesses the risk of various cancers, and the Myriad Prequel® test for prenatal screening. These services are distinguished by their comprehensive approach and commitment to accuracy, helping healthcare providers make informed decisions. Recognised for its significant contributions to women's health, Myriad Women's Health continues to enhance its market position through ongoing research and development, aiming to improve health outcomes for women across the globe.
We don't have data for Myriad Women's Health, Inc., but we can show you information about their parent organization instead.
View parent company